Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0900
+0.0030 (3.45%)
Mar 26, 2026, 11:17 AM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $15.07 million as of March 26, 2026. Its market cap has decreased by -18.85% in one year.
Market Cap
15.07M
Enterprise Value
12.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has increased from 14.08M to 15.07M, an increase of 7.09%. That is a compound annual growth rate of 0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 15.07M | 94.11% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 20.23M |
| Oncotelic Therapeutics | 16.71M |
| Zeo ScientifiX | 15.24M |
| HOOKIPA Pharma | 13.50M |
| Finch Therapeutics Group | 11.72M |
| Nymox Pharmaceutical | 11.43M |
| Brainstorm Cell Therapeutics | 9.57M |
| BetterLife Pharma | 9.51M |